MENU

Cell Lines

Technology Transfer Contacts
(technologies available for licensing)
Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11
 
TECH ID   TITLE  LEAD INVENTOR   CONTACT  

 01-04

FC-mMCL-1 murine mantle cell lymphoma model cell line

Abstract

 Mitchell Smith

Tatiana Venkova

 01-21

 N38-2C12/Va14+ T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 01-22

 

 N38-2C12/ Bv8.2 T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 02-27

 BEAS-2B-BW1799 xenograft-derived human bronchial epithelial cells (control)

Abstract

 Andres Klein-Szanto

Tatiana Venkova

 02-28

BEAS-2B-CSC 1198 xenograft-derived human bronchial epithelial cells (non-tumor derived)

Abstract

 Andres Klein-Szanto

Tatiana Venkova

 02-29

BEAS-2B-CSC 1170-I xenograft-derived human bronchial epithelial cells (tumor derived)

Abstract

 Andres Klein-Szanto

Tatiana Venkova

 03-21

OVCAR-3 ovarian carcinoma cell line from a patient refractory to cisplatin

Abstract

Thomas Hamilton

Tatiana Venkova

 03-22

OVCAR-4 ovarian carcinoma cell line from a patient refractory to cisplatin

Abstract

Thomas Hamilton

Tatiana Venkova

 03-23

OVCAR-5 ovarian carcinoma cell line from untreated advanced tumor

Abstract

Thomas Hamilton

Tatiana Venkova

 03-26

A2780 ovarian cancer cell line (cisplatin sensitive) derived from patient prior to treatment

 

 Thomas Hamilton 

Tatiana Venkova

 03-32R

MOVCAR cell lines

Abstract

 Denise Connolly

Natalia Shalginskikh

 04-30

A2780/CP70 and CP30 cisplatin-resistant cell lines

Abstract

Thomas Hamilton 

Tatiana Venkova

 05-18

 Mesothelioma cell lines

Abstract

 Joseph Testa

Natalia Shalginskikh

07-14

PE01 human ovarian cancer cell line

 

Thomas Hamilton 

Tatiana Venkova

 07-28

 N38-3C3 NK T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 95-13

 HepAD38: tet-inducible HBV expression cell line 

Abstract

 Christoph Seeger

Natalia Shalginskikh

 99-31

 HepG2.2.15 cell line

Abstract

 Marianne Sells

Tatiana Venkova

 120-RK

 Inducible HeLa TI-C GFP cells

Abstract

 Richard Katz

Natalia Shalginskikh

 133-JR

bsMCF: triple-negative breast cancer, Boyden chamber-selected tumorigenic cells

Abstract

 Jose Russo

Natalia Shalginskikh

 134-JR

trMCF: triple-negative breast cancer, estradiol-transformed cells

Abstract

 Jose Russo

Natalia Shalginskikh

 150-WM

 LMH-D2 duck hepatitis B virus-expressing cell line

 

 William Mason 

Tatiana Venkova

 156-KH

N37-1A12 T-cell hybridoma

Abstract

 Kyoko Hayakawa

Tatiana Venkova

 191-CS

Dstet5 cells

Abstract

 Christoph Seeger

Natalia Shalginskikh

 249-JT

Murine Thymic Lymphoma cells from Lck-Akt2 mice

Abstract

 Joseph Testa

Natalia Shalginskikh

 263-DB

Liposarcoma cell line  LS2

 

 Margaret von Mehren

Natalia Shalginskikh

 272-JT

APPL1KO/WT MEF (murine embryonic fibroblasts)

Abstract

 Joseph Testa

Natalia Shalginskikh

 295-CS

HeLa HCV replicon 

Abstract

 Christoph Seeger

Natalia Shalginskikh

 344-JR

T4 cell line

 

 Jose Russo

Natalia Shalginskikh

 353-DW

Scid.adh: a thymic cell line that mimics T-cell development invitro

Abstract

 David Wiest

Natalia Shalginskikh

 379-CS

NTCP-HepG2 cell line

Abstract

 Christoph Seeger

Natalia Shalginskikh

 382-CS

NTCP-Cas9-HepG2 cell line

 

 Christoph Seeger

Natalia Shalginskikh

 384-CS

Hep AD38-Cas9 cell line

 

 Christoph Seeger

Natalia Shalginskikh

 451-HB

HEK293-MRP3 cells

 

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 452-HB

HEK293-pcDNA Vector control cell line for MRP cells

 

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 453-HB

HEK293-MRP7-C17 cells 

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 454-HB

MEF 405 (MRP -/-, Pgp -/-) cells

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 455-HB

MEF 205 (MRP +/+, Pgp -/-) cells

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 456-HB

HEK293-MRP7-C18 cells 

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 457-HB

MEF 237 (MRP -/-, Pgp +/+) cells

Abstract

 Elizabeth Hopper-Borge

Natalia Shalginskikh

 458-JR

LmMCF cell line: triple-negative breast cancer cells derived from lung metastasis of bsMCF cells

Abstract

 Jose Russo

Natalia Shalginskikh

 459-JR

XtMCF cell line:  triple-negative breast cancer cells derived from xenograft of bsMCF cells

Abstract

 Jose Russo

Natalia Shalginskikh

 468-SA

EBV-B cell line from a patient with renal cancer carrying mutation in the intronic region of RRM2B gene 

Sanjeevani Arora

Tatiana Venkova

 478-LW 

B16BL6-D5-HER2 cell line

Abstract

 Louis Weiner

Natalia Shalginskikh

 

 03-05

CD16.NK-92 cells (exclusively licensed)

Please contact Dr. Campbell for more information if you are interested in a sublicense

Patent No. US7618817B2; Patent No. US8313943B2

 Kerry Campbell

Kerry Campbell

 

Connect with Fox Chase